GIPR and non-small cell lung carcinoma: We show that the IL‐11 GIPR variant is an agonist cytokine that induces increased pSTAT3 signaling as compared with WT IL‐11 in the HeLa reporter cells and A549 human non‐small cell lung cancer cells (NSCLC; Figure 2d,e).